Development
Johnson & Johnson
JNJ
$155.03
$1.370.89%
NYSE
| 12/31/2023 | 10/01/2023 | 07/02/2023 | 04/02/2023 | 01/01/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.30% | 6.78% | 6.24% | 5.63% | -19.61% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.30% | 6.78% | 6.24% | 5.63% | -19.61% |
| Cost of Revenue | 10.37% | 3.37% | 4.47% | 7.86% | -24.14% |
| Gross Profit | 5.95% | 8.30% | 6.95% | 4.57% | -17.45% |
| SG&A Expenses | 8.40% | 8.85% | 2.70% | 2.64% | -27.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.30% | 4.08% | 3.60% | 5.07% | -24.84% |
| Operating Income | -7.24% | 13.63% | 12.95% | 7.03% | 0.79% |
| Income Before Tax | 25.68% | 0.87% | 28.34% | -112.57% | -20.60% |
| Income Tax Expenses | 13.21% | 5.34% | 0.25% | -193.83% | 513.00% |
| Earnings from Continuing Operations | 28.04% | -0.02% | 34.45% | -101.32% | -31.86% |
| Earnings from Discontinued Operations | -128.33% | 14,575.00% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.03% | 483.85% | 6.86% | -101.32% | -25.68% |
| EBIT | -7.24% | 13.63% | 12.95% | 7.03% | 0.79% |
| EBITDA | -0.64% | 12.46% | 12.39% | 6.87% | -9.74% |
| EPS Basic | 8.53% | 508.15% | 7.99% | -101.33% | -25.06% |
| Normalized Basic EPS | -26.46% | 19.69% | 30.17% | 10.00% | 22.50% |
| EPS Diluted | 10.60% | 509.23% | 8.61% | -101.55% | -25.38% |
| Normalized Diluted EPS | -25.37% | 19.94% | 29.42% | 11.55% | 22.55% |
| Average Basic Shares Outstanding | 5.39% | -4.00% | -1.04% | -0.90% | -0.25% |
| Average Diluted Shares Outstanding | 3.86% | -4.19% | -1.51% | -2.29% | -0.31% |
| Dividend Per Share | 5.31% | 5.31% | 5.31% | 6.60% | 6.60% |
| Payout Ratio | 0.09% | -- | 1.06% | -80.93% | 0.10% |